20 hrs ago

Nomura Cuts PB Fintech Target After Proposed Insurance Commission Caps

Nomura Cuts PB Fintech Target After Proposed Insurance Commission Caps
PB Fintech down 45% since IRDAI proposal; Nomura slashes target, FY28 PAT estimates by 72% · financialexpress.com

PB Fintech is a company that sells insurance products.

Its shares have fallen nearly 45% in recent weeks as investors consider a proposal to limit insurance commissions.

Nomura lowered the price it thinks the shares could reach, but kept its rating at Neutral.

In its main forecast, the brokerage expects much lower profits in FY28 and FY29 than it had previously estimated.

It also considered what might happen if health insurance commission limits were a little higher.

Under that assumption, its FY28 profit estimate would be higher than in the main forecast.

Another scenario assumes the company sells traditional savings products.

Nomura says that could also improve its profit estimates, though less than the higher-commission scenario.

These are brokerage estimates, not guaranteed outcomes or investment advice.

Key facts

Share price decline
Nearly 45% in recent weeks.
Nomura target price
Reduced 31% to Rs 1,100 per share.
Nomura rating
Neutral.
Current share price cited
Rs 1,012 per share.
Base-case FY28 net profit estimate
Cut by 72%.
Base-case FY29 net profit estimate
Cut by 51%.
Higher-cap scenario
Assumes health insurance commission caps two percentage points above the proposal; FY28 net profit estimate is 37% above the base case.
Savings-product scenario
Assumes new savings products make up 0.5–1.1% of total premium mix in FY28–FY29; fair price estimated at Rs 1,366.

Quotes

Nomura

Japanese brokerage that revised its financial estimates and target price for PB Fintech.

“PB Fintech has been arguing that its support to customers at the time of hospital discharge is a key offering that improves customer experience. Thus, in our first scenario (S1) we assume a 2pp (percentage point) higher commission cap vs what has been proposed currently for the health insurance segment. We make no other changes in our S1 vs our base case.”
financialexpress.com
“We now expect a FY26-50F revenue CAGR in discounted cash flow (DCF) of 13.2% vs 15.1% earlier.”
financialexpress.com

Sources

Related news